Bruce Jancin
![1]()
News
TNF inhibitors may dampen COVID-19 severity
May 19, 2020
New findings from the COVID-19 Global Rheumatology Alliance Registry.
![1]()
News
ER docs ask, “Where are our patients?”
May 14, 2020
“The safest place in the world to be right now is the ED.” – Dr. Donald M. Yealy.
![1]()
News
Coronary CT angiography gives superior MI risk prediction
May 8, 2020
Low-attenuation noncalcified plaque burden cuts to the heart of cardiovascular risk prediction.
News
COVID-19: No U.S. spike expected in pandemic-related suicidal ideation
April 29, 2020
Big Data analysis of real-time Crisis Text Line experience offers encouragement.
![1]()
News
European COVID-19 insights: Try helmet CPAP
April 23, 2020
An older, relatively inexpensive form of noninvasive ventilation appears to prevent self-induced lung injury.
![1]()
News
HFpEF: Gender difference in sacubitril/valsartan response remains mystery
April 17, 2020
Why did women on sacubitril/valsartan get a 27% reduction in cardiovascular death and heart failure hospitalization, while the men got nothing?
![1]()
News
PARAGON-HF: Optimal systolic pressure in HFpEF is 120-129 mm Hg
March 18, 2020
In largest-ever HFpEF trial, SBP of 120-129 mm Hg was associated with lowest cardiovascular risk.
![1]()
News
Tools for preventing heart failure
February 13, 2020
SNOWMASS, COLO. – “There will be more than 1 million new cases of heart failure this year, and the vast majority of them could have been prevented.” – Gregg C. Fonarow, MD
![1]()
News
Cardiac arrest: Targeted temperature management a game changer
February 5, 2020
SNOWMASS, COLO. – “There are essentially no patients for whom temperature control somewhere in the range between 32 degrees C and 36 degrees C is contraindicated.”
![1]()
News
What 2019’s top five CAD trials tell us
January 29, 2020
SNOWMASS, COLO. – Triple therapy as a triple threat – a three-pronged threat to patient safety, Dr. Malcolm R. Bell says.
